Alimera announces issuance of positive appraisal recommendation on Iluvien

theflyonthewall.com

Alimera Sciences announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence, or NICE, has issued a positive Appraisal Consultation Document, or ACD, on Iluvien for the treatment of pseudophakic patients with chronic diabetic macular edema, or DME, considered insufficiently responsive to available therapies. The ACD recommends a change to the published guidance issued by NICE on January 29, and takes into consideration a simple patient access scheme, or PAS, that was submitted by Alimera for rapid review.

View Comments (0)